Baseline PSA Screening During Midlife Predicts Prostate Cancer in Black Men, Study Finds

Baseline PSA Screening During Midlife Predicts Prostate Cancer in Black Men, Study Finds
Measuring PSA levels during midlife — between 40 and 64 years — could help predict the likelihood an African-American man has of developing prostate cancer up to 12 years after the analysis, a study shows. The study, "Baseline Prostate-specific Antigen Level in Midlife and Aggressive Prostate Cancer in Black Men," was published in the journal European Urology. The prostate-specific antigen (PSA) is an enzyme produced by the prostate gland that has long been used to diagnose prostate cancer. The test originally was approved in 1986, but studies since suggest it also could lead to the diagnosis and treatment of cancers that may present
Subscribe or to access all post and page content.

2 comments

  1. Christopher O'Neill says:

    Detecting any type of Prostate Cancer is quite easy. Actually saving lives from Prostate Cancer is entirely far more difficult and uncertain.

Leave a Comment

Your email address will not be published. Required fields are marked *